glp-1-receptoragonister Trends in the Development of GLP-1 Receptor Agonists GLP-1 Receptor Agonists: Trend, Necessity,
Description
LEADER Steering Committee on behalf of the LEADER Trial Investigators
While this body of evidence is highly encouraging, it is important to note that these findings are derived from studies with considerable methodological heterogeneity, a limitation that will be addressed in the Discussion
Reduced movement can accelerate muscle atrophy
0.0% with placebo, and decreased appetite (19.0% and 18.2%) vs
Najdawi, F
